Kevin Wirges - CareMax CFO VP
| CMAX Stock | USD 0.69 0.03 4.17% |
Insider
Kevin Wirges is CFO VP of CareMax
| Age | 44 |
| Address | 1000 NW 57th Court, Miami, FL, United States, 33126 |
| Phone | 786 360 4768 |
| Web | https://www.caremax.com |
Kevin Wirges Latest Insider Activity
Tracking and analyzing the buying and selling activities of Kevin Wirges against CareMax stock is an integral part of due diligence when investing in CareMax. Kevin Wirges insider activity provides valuable insight into whether CareMax is net buyers or sellers over its current business cycle. Note, CareMax insiders must abide by specific rules, including filing SEC forms every time they buy or sell CareMax'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Kevin Wirges over a month ago Acquisition by Kevin Wirges of 4433 shares of CareMax subject to Rule 16b-3 | ||
Kevin Wirges over six months ago Acquisition by Kevin Wirges of 13300 shares of CareMax at 10.0 subject to Rule 16b-3 |
CareMax Management Efficiency
The company has return on total asset (ROA) of (0.1059) % which means that it has lost $0.1059 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.2842) %, meaning that it created substantial loss on money invested by shareholders. CareMax's management efficiency ratios could be used to measure how well CareMax manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -1.78 in 2024. Return On Capital Employed is likely to rise to -3.38 in 2024. At this time, CareMax's Other Current Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 26 M in 2024, despite the fact that Net Tangible Assets are likely to grow to (175 M).Similar Executives
| Showing other executives | INSIDER Age | ||
| Andrew Schemick | Certara | 50 | |
| Jon Boumstein | National Research Corp | N/A | |
| Adam Dublin | Forian Inc | 58 | |
| Peter Grua | Evolent Health | 66 | |
| Jason Jones | Health Catalyst | N/A | |
| Jona Raasch | National Research Corp | 65 | |
| Paul Horstmeier | Health Catalyst | 63 | |
| William Feehery | Certara | 53 | |
| Jaap Mandema | Certara | N/A | |
| M Duffy | Evolent Health | 61 | |
| Andrew Douglas | Forian Inc | N/A | |
| Jim MD | Privia Health Group | N/A | |
| Gregory MS | National Research Corp | N/A | |
| Tyson Murdock | HealthEquity | 53 | |
| Helen Hrdy | National Research Corp | 59 | |
| MAAA FSA | Evolent Health | 51 | |
| Matthew Morris | Privia Health Group | 60 | |
| Daniel Barton | Forian Inc | 59 | |
| Kali Beyah | Evolent Health | N/A | |
| Nicolette Sherman | Certara | 54 | |
| Max Wygod | Forian Inc | 36 | |
Management Performance
| Return On Equity | -3.28 | ||||
| Return On Asset | -0.11 |
CareMax Leadership Team
Elected by the shareholders, the CareMax's board of directors comprises two types of representatives: CareMax inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CareMax. The board's role is to monitor CareMax's management team and ensure that shareholders' interests are well served. CareMax's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CareMax's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alberto Solo, Executive COO | ||
| Carlos Solo, President, CoFounder | ||
| Samantha Swerdlin, Vice Relations | ||
| Niberto MD, Chief Officer | ||
| Nicole Cable, Chief Officer | ||
| Teresa McMeans, Chief Officer | ||
| Erick CPA, Chief Officer | ||
| Meredith Longsworth, General VP | ||
| Roger Ou, SVP Relations | ||
| Paul Rundell, Chief Officer | ||
| Meredith JD, General VP | ||
| Kevin Wirges, CFO VP | ||
| Erick Fernandez, Chief Officer | ||
| Mark Llorente, Chief Operations | ||
| Michael Jarjour, Chief Officer | ||
| Regla Wuilchrist, Chief Officer |
CareMax Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CareMax a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.28 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (1.00) % | ||||
| Operating Margin | (0.1) % | ||||
| Current Valuation | 499.52 M | ||||
| Shares Outstanding | 3.81 M | ||||
| Shares Owned By Insiders | 24.17 % | ||||
| Shares Owned By Institutions | 51.59 % | ||||
| Number Of Shares Shorted | 463.58 K | ||||
| Price To Book | 0.40 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CareMax Stock Analysis
When running CareMax's price analysis, check to measure CareMax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CareMax is operating at the current time. Most of CareMax's value examination focuses on studying past and present price action to predict the probability of CareMax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CareMax's price. Additionally, you may evaluate how the addition of CareMax to your portfolios can decrease your overall portfolio volatility.